|
Pronunciation |
|
(zingk
KLOR
ide) |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Trace Element |
|
|
Use |
|
Cofactor for replacement therapy to different enzymes helps maintain normal
growth rates, normal skin hydration and senses of taste and
smell |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Adverse
Reactions |
|
<1%:
Gastrointestinal: Indigestion, nausea, vomiting
Hematologic: Neutropenia, leukopenia
Hepatic: Jaundice
Respiratory: Pulmonary edema |
|
|
Usual Dosage |
|
Clinical response may not occur for up to 6-8 weeks
Premature Infants <1500 g, up to 3 kg: 300 mcg/kg/day
Full-term Infants and Children less than or equal to 5 years: 100 mcg/kg/day
Adults:
Stable with fluid loss from small bowel: 12.2 mg zinc/liter TPN or 17.1 mg
zinc/kg (added to 1000 mL I.V. fluids) of stool or ileostomy output
Metabolically stable: 2.5-4 mg/day, add 2 mg/day for acute catabolic states
|
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Nursing
Implications |
|
Patients on TPN therapy should have periodic serum copper and serum zinc
levels |
|
|
Dosage Forms |
|
Injection: 1 mg/mL (10 mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|